SWM
EW icon

SHP Wealth Management’s Edwards Lifesciences EW Stock Holding History

SHP Wealth Management’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$12.1K Buy
134
+53
+65% +$4.44K ﹤0.01% 906
2026
Q1 		$6.48K Buy
81
+78
+2,600% +$6.43K ﹤0.01% 1008
2025
Q4 		$248 Buy
+3
New +$246 ﹤0.01% 1452

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

SHP Wealth Management's EW Position: Q2 2026 in Review

SHP Wealth Management increased its Edwards Lifesciences (EW) stake by 65% in Q2 2026, buying an estimated $4.44K and bringing the position to 134 shares worth $12.1K. The position accounts for ﹤0.01% of the portfolio, ranked #906.

SHP Wealth Management first reported a position in EW in Q4 2025 and has held it in 3 quarters since. 1,337 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • SHP Wealth Management held 134 shares of Edwards Lifesciences worth $12.1K as of Q2 2026.
  • SHP Wealth Management bought 53 Edwards Lifesciences shares in Q2 2026, an estimated $4.44K.
  • Edwards Lifesciences made up ﹤0.01% of SHP Wealth Management's portfolio in Q2 2026, its #906 holding.
  • SHP Wealth Management first reported a position in Edwards Lifesciences in Q4 2025 and has held it in 3 quarters since.
  • 1,337 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on SHP Wealth Management's 13F filing for Q2 2026, filed 11 Aug 2026.